PKM and gastric cancer: In gastric cancer cells, cytoplasmic β-Arrestin1 (ARRB1) binds to pyruvate kinase M2 (PKM2), inhibiting PKM2 tetramerization, decreasing its enzymatic activity, and modulating metabolic flux, thereby shifting cellular metabolism from oxidative phosphorylation to aerobic glycolysis (51).